Early Phase Archives

ePRO for Early Phase Studies: 3 Ways To Benefit

March 20, 2023

Adopting ePRO in early-phase trials can revolutionize data collection, reduce participant burden and increase the accuracy of results. Not only does this improve patient care, but it also provides commercial advantages to sponsors.

[Webinar Recap] 5 Supply Management Success Factors for Your Early Phase Studies

September 21, 2022

Why it is time to rethink the status quo around randomization and supply management in early phase studies?

5 Supply Management Success Factors for Your Early Phase Studies

September 13, 2022

Many early phase studies rely on manual methods of managing participant randomization and the study supply chain. But increasing complexities in both study design and global supply chain necessitate more flexible, responsive solutions for early…

How to Address Early Obstacles in Phase I

June 10, 2021

It’s no secret that getting new drugs or biological products approved by the FDA is a challenging task. The low rates at which drugs make it all the way through the research process is a…

Adaptive Trials: Is Your Study Equipped To Adapt?

May 20, 2019

Imagine, for a moment, you’re a data manager overseeing a Phase I study. Your endpoints are set, your database built and deployed, and your data collected. Now it’s time to cross your fingers, unblind your…

Avoiding Headaches In Today’s Complex Phase I Landscape

May 16, 2019

Statistics suggest that Phase I clinical trials, while by no means free of challenges, are more manageable than later phases. They tend to take less time and cost less money; the drugs they test have…

3 Early Obstacles in Phase I Clinical Trials, And How to Address Them

April 15, 2018

Anyone with an involvement or interest in clinical research is likely to be aware of the challenges sponsors face in getting their compounds approved by the FDA. The low rates at which drugs make it…

Early Phase